Genomed Spólka Akcyjna Statistics

Total Valuation

WSE:GEN has a market cap or net worth of PLN 34.09 million. The enterprise value is 29.30 million.

Market Cap	34.09M
Enterprise Value	29.30M

Important Dates

The next estimated earnings date is Monday, August 11, 2025.

Earnings Date	Aug 11, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:GEN has 1.32 million shares outstanding.

Current Share Class	648,283
Shares Outstanding	1.32M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	44.76%
Owned by Institutions (%)	n/a
Float	41,650

Valuation Ratios

The trailing PE ratio is 17.38.

PE Ratio	17.38
Forward PE	n/a
PS Ratio	1.40
PB Ratio	3.11
P/TBV Ratio	3.13
P/FCF Ratio	20.76
P/OCF Ratio	16.05
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.69, with an EV/FCF ratio of 17.84.

EV / Earnings	14.93
EV / Sales	1.21
EV / EBITDA	10.69
EV / EBIT	14.82
EV / FCF	17.84

Financial Position

The company has a current ratio of 7.82

Current Ratio	7.82
Quick Ratio	6.46
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	9,504.30

Financial Efficiency

Return on equity (ROE) is 19.23% and return on invested capital (ROIC) is 12.11%.

Return on Equity (ROE)	19.23%
Return on Assets (ROA)	10.63%
Return on Invested Capital (ROIC)	12.11%
Return on Capital Employed (ROCE)	17.47%
Revenue Per Employee	457,889
Profits Per Employee	37,017
Employee Count	54
Asset Turnover	2.09
Inventory Turnover	4.56

Taxes

In the past 12 months, WSE:GEN has paid 108,053 in taxes.

Income Tax	108,053
Effective Tax Rate	5.22%

Stock Price Statistics

The stock price has decreased by -7.14% in the last 52 weeks. The beta is -0.21, so WSE:GEN's price volatility has been lower than the market average.

Beta (5Y)	-0.21
52-Week Price Change	-7.14%
50-Day Moving Average	25.34
200-Day Moving Average	27.79
Relative Strength Index (RSI)	58.30
Average Volume (20 Days)	43

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:GEN had revenue of PLN 24.27 million and earned 1.96 million in profits. Earnings per share was 1.48.

Revenue	24.27M
Gross Profit	15.56M
Operating Income	1.98M
Pretax Income	2.07M
Net Income	1.96M
EBITDA	2.74M
EBIT	1.98M
Earnings Per Share (EPS)	1.48

Full Income Statement

Balance Sheet

The company has 4.79 million in cash and n/a in debt, giving a net cash position of 4.79 million or 3.63 per share.

Cash & Cash Equivalents	4.79M
Total Debt	n/a
Net Cash	4.79M
Net Cash Per Share	3.63
Equity (Book Value)	10.96M
Book Value Per Share	8.29
Working Capital	8.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.12 million and capital expenditures -482,320, giving a free cash flow of 1.64 million.

Operating Cash Flow	2.12M
Capital Expenditures	-482,320
Free Cash Flow	1.64M
FCF Per Share	1.24

Full Cash Flow Statement

Margins

Gross margin is 64.11%, with operating and profit margins of 8.15% and 8.08%.

Gross Margin	64.11%
Operating Margin	8.15%
Pretax Margin	8.53%
Profit Margin	8.08%
EBITDA Margin	11.30%
EBIT Margin	8.15%
FCF Margin	6.77%

Dividends & Yields

WSE:GEN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	5.76%
FCF Yield	4.82%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

WSE:GEN has an Altman Z-Score of 17.47 and a Piotroski F-Score of 7.

Altman Z-Score	17.47
Piotroski F-Score	7